Amneal launches three generic liquid drugs

BRIDGEWATER, N.J. — Generic drug maker Amneal has launched three new liquid drugs, the company said Monday.

Amneal announced the launch of risperidone oral solution, a generic version of Johnson & Johnson’s schizophrenia and bipolar disorder treatment Risperdal, in the 1-mg/mL strength; ondansetron oral solution, a generic version of GlaxoSmithKline’s Zofran used to prevent nausea and vomiting associated with cancer treatment and postoperative recovery, in the 4-mg/5-mL strength; and levetiracetam oral solution, a generic version of UCB Pharma’s epilepsy drug Keppra, in the 100-mg/mL strength. The generic versions of Zofran and Keppra are respectively available in strawberry-scented and grape-flavored liquids.

“Since Amneal’s acquisition of its Branchburg, N.J., liquids plant a few years ago, we have committed significant [research and development] resources to developing a powerful product pipeline in the liquid, nasal spray and topical dosage forms that are now beginning to come to market,” Amneal president Chirag Patel said in a statement. “And the most exciting products are still to come, enhancing an already strong pipeline.”

Login or Register to post a comment.